glp 1 gastroparesis treatment GLP-1 Gastroparesis: Hidden Dangers Beyond C GLP-1 Receptor Agonists and Gastrointestinal
Description
Originally developed to help manage Type 2 diabetes, these medications have shown significant promise in the weight loss space, helping patients feel fuller longer, reduce cravings, and control portion sizes
3A and J) and vWF (Fig
Glucagon-like peptide I improved glycemic control in type I diabetes
Willpower Fatigue Replaces mental effort with hormonal regulation
An imbalance in the gut microbial community can trigger inflammatory responses and modulate GLP-1 secretion, while GLP-1 itself may influence both immune signaling and microbial composition
Newer medicines, such as tirzepatide (Mounjaro), also act on a second hormone, offering additional benefits for weight and metabolic control
